Jan 2026· International Journal of Pediatrics· Vol 2026· 0 citations· 15 references
Medicine
TL;DR
Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development.
Abstract
Background Depression and anxiety occur in about 10% of pregnancies. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed, but their potential effects on fetal neurodevelopment remain uncertain. Because serotonin influences brain maturation, prenatal SSRI exposure may affect later cognition, language, or motor function. Methods This systematic review and meta‐analysis evaluated whether prenatal SSRI exposure is associated with differences in child cognitive, language, or psychomotor development. PubMed and Scopus were searched through June 2025 for cohort, case‐control, or randomized studies reporting standardized neurodevelopmental outcomes in children (0–18 years) with documented in utero SSRI exposure compared with unexposed controls. Two reviewers independently screened studies, extracted data, and assessed bias (Newcastle–Ottawa Scale; RoB‐2). Random‐effects meta‐analyses estimated standardized mean differences (SMDs) with 95% confidence intervals (CIs). Results Of 250 records identified, 17 studies met inclusion criteria, and 9 contributed to meta‐analysis. For general cognition, pooled SMD = −0.20 (95% CI −0.50 to 0.10) showed no significant difference between groups. Sensitivity analyses restricted to SSRI‐only cohorts and Bayley‐specific instruments yielded similar findings. Secondary outcomes also showed no differences: receptive language (SMD = 0.04; 95% CI −0.16 to 0.23), expressive language (SMD = −0.17; 95% CI −0.40 to 0.06), and psychomotor development (SMD = −0.18; 95% CI −0.67 to 0.31). Conclusions Current evidence does not support a clinically meaningful impact of prenatal SSRI exposure on early cognitive, language, or psychomotor development. Observed effects were small, imprecise, and diminished when analyses were limited to SSRI‐only cohorts and harmonized outcome measures.
OBJECTIVE
To evaluate associations of prenatal exposure to stimulants and atomoxetine for attention-deficit/hyperactivity disorder with pregnancy, congenital, perinatal, and neurodevelopmental outcomes.
DATA SOURCES
PubMed, Embase, Cochrane Library, and Web of Science were searched from inception to March 2026. Proto...
Rinat Komargodski, Abeer Tillawe, Maya Berlin et al.· American Journal of Obstetri...· 0 citations
This systematic review and network meta-analysis aimed to compare the effects of non-pharmacological intervention categories on attention, working memory, comprehensive executive function, and social-emotional cognition in children with autism spectrum disorder. Five databases were searched for randomized controlled tr...
Miao-Wen Zheng, Shu-Ning Liu, Yan-Qing Wei et al.· Asian Journal of Psychiatry· 0 citations
The claim of "strong evidence" for an acetaminophen-neurodevelopmental-disorder association was not supported by this reanalysis, as a modest ADHD association persisted, while ASD and other-NDD estimates moved toward the null.
A. Grover, J. Reis-Pardal, R. Ellis et al.· medRxiv· 0 citations
Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD, however, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established.
Guang-Nan Mei, Jin Gan, Ya-Fang Xia et al.· Acta paediatrica· 0 citations
AIM
Cannabis use during pregnancy has increased, raising concerns about potential effects on offspring brain development. The objective of this systematic review was to evaluate MRI-based evidence on the association between prenatal cannabis exposure (PCE) and offspring brain development across structural, diffusion, r...
Elaheh Karimi, Arash Safari Sabet, M. Terplan et al.· Neurotoxicology and Teratolo...· 0 citations
Purpose of the Review: Sex-based differences in antidepressant outcomes may influence treatment decisions in major depressive disorder (MDD). This systematic review and meta-analysis evaluated sex-based differences in the efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) in adults with MDD. C...
Amrita Kumari Pandey, Abhinav Tiwary, F. Khan et al.· Indian Journal of Psychologi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.